Clinical trial
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
NCT00089141
Study timeline
Study start (unknown)2004-05-01Date precision: month
Registry last updated2013-05-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cancerunresolved
Interventions
mycophenolate mofetilDRUG · verified · RxNorm: mycophenolate mofetil
placeboDRUG
Sponsors & collaborators
Martin, Paullead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
SeattleWashington, United States2HoustonTexas, United States1ChicagoIllinois, United States1DallasTexas, United States1TorontoOntario, Canada1San AntonioTexas, United States1NashvilleTennessee, United States1PortlandOregon, United States1MinneapolisMinnesota, United States1OmahaNebraska, United States1Ann ArborMichigan, United States1GainesvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00089141 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.